...
首页> 外文期刊>Nephrology. >Pneumocystis jirovecii colonization among renal transplant recipients
【24h】

Pneumocystis jirovecii colonization among renal transplant recipients

机译:肾移植受者中肺孢菌的定殖

获取原文
获取原文并翻译 | 示例
           

摘要

Aim Renal transplant recipients are at risk of developing Pneumocystis pneumonia (PcP), especially in the first 2 years after transplantation, with a mortality rate of up to 50%. No data are available on pulmonary colonization with Pneumocystis jirovecii in renal transplant recipients. The aim of this study was to determine the prevalence of pulmonary colonization with Pneumocystis jirovecii in renal transplant recipients and to find related risk factors. Methods We investigated the induced sputa of 70 renal transplant recipients for the presence of Pneumocystis jirovecii using nested polymerase chain reaction. Results Thirteen of 70 patients (18.6%) were colonized with Pneumocystis jirovecii. There was no significant correlation between colonization and immunosuppressive medication or regimens. However, colonized subjects had undergone transplantation longer ago than non-colonized subjects. 30.8% of those whose transplantation had taken place more than 8 years previously were colonized, in contrast to 11.4% of those whose transplantation had taken place less than 8 years ago (P = 0.059; odds ratio = 3.467, 95% confidence interval = 0.99-12.09). Conclusion Most cases of Pneumocystis colonization were detected in those patients where renal transplantion had taken place more than 2 years previously. As most PcP cases occur within the first 2 years of transplantation, colonization does not seem to play a role in the development of acute PcP in this period. Though Pneumocystis pneumonia is likely to be a newly acquired infection in the first 2 years after transplantation, colonized patients remain a potential source of transmission of Pneumocystis jirovecii. Summary at a Glance Availability of highly sensitive diagnostic molecular techniques for DNA amplification has allowed detection of minute burdens of Pneumocystis organisms in human hosts. This study addressed the prevalence of Pneumocystis jirovecii pulmonary colonization in a cohort of 70 renal transplant recipients. Additional studies to investigate whether Pneumocystis colonization in transplant recipients are of clinical significance are warranted.
机译:目的肾移植受者有发展成肺囊虫性肺炎(PcP)的风险,尤其是在移植后的前2年,死亡率高达50%。在肾移植受者中,尚无关于吉氏肺孢子虫肺定植的数据。这项研究的目的是确定在肾移植受者中肺炎败血性肺孢菌的定殖率,并寻找相关的危险因素。方法我们使用巢式聚合酶链反应研究了70例肾移植受者诱导的痰液中是否存在jirovecii肺孢子虫。结果70例患者中有13例(18.6%)感染了吉氏肺孢子虫。定植与免疫抑制药物或治疗方案之间无显着相关性。但是,定植的对象比未定植的对象接受移植的时间更长。移植超过8年的患者中有30.8%被定殖,而移植不到8年的患者中有11.4%被定植(P = 0.059;优势比= 3.467,95%置信区间= 0.99 -12.09)。结论大多数在2年前进行肾脏移植的患者中检出了肺孢子菌定植的病例。由于大多数PcP病例都发生在移植的前2年内,因此在此期间,定植似乎在急性PcP的发生中不起作用。尽管肺孢菌肺炎可能是在移植后的头2年内新获得的感染,但定植的患者仍然是吉氏肺孢子菌传播的潜在来源。概述摘要用于DNA扩增的高度灵敏的诊断分子技术的可用性已使人们能够检测出人体宿主中微小的肺孢子菌生物体负担。这项研究解决了70名肾移植受者队列中的吉氏肺孢子虫肺定植的情况。有必要进行其他研究以调查移植受者中的肺孢子虫定植是否具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号